ArticleRadiation research2026
Methyl Quercetin Inhibits Radiation-induced Senescence and TGF-β1-induced Myofibroblast Differentiation Through psmad3/TGF-β Signaling.
Article in Radiation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Previously, we demonstrated that continuous oral delivery of quercetin attenuated radiation-induced dermal fibrosis in C3H/HeN mice exposed to 35 Gy of ionizing radiation. Quercetin was rapidly metabolized and primarily detected in plasma, liver, and urine as methylated metabolites. The current study aimed to investigate the biological effects of methylated quercetin on radiation-induced cellular senescence and macrophage polarization, and to evaluate its therapeutic potential for ameliorating radiation-induced skin fibrosis. Skin tissue was collected from C3H/HeN mice fed quercetin-formulated or control chow and exposed to 0 Gy or 35 Gy at 150 days postirradiation. In mice irradiated with 35 Gy, quercetin chow administration reduced epidermis thickness, the number of cells that were positive for senescent markers (p21, p16) positive cells and vimentin-positive cells in the skin, compared with control chow administration. Also, the number of cells positive for macrophage markers (F4/80, CD206) were decreased. These in vivo results were consistent with findings in NIH/3T3 fibroblasts irradiated with either 0 Gy or 17.5 Gy in the presence of 3-O-methylquercetin (MQ) or vehicle. X-gal staining and p21 expression detected by Western blotting indicated that radiation-induced cellular senescence, but it was decreased by pretreatment of MQ. Senescence-associated secretory phenotype (SASP) factors including TGF-β1 and Pai-1 were significantly higher in the irradiated fibroblasts but decreased in the presence of MQ. In addition, MQ pretreatment reduced cell proliferation and vimentin expression via canonical TGF-β1 signaling. Furthermore, conditioned media (CM) from irradiated fibroblasts induced M2 polarization of Raw264.7 macrophages, whereas CM from MQ-treated irradiated fibroblasts decreased M2 macrophage expression. Taken together, these results indicate that MQ is a potential senomorphic agent, reducing SASP expression to mitigate radiation-induced skin senescence and macrophage polarization, and exerting protective effects against radiation-induced skin fibrosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.